Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (161-170 of 368) with videos related to

Pageof 37
Sort By:
Virus Research|March 28, 2025
Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogeneticsHossain M S Sazzad, Hui Li, Behzad Hajarizadeh, et al.
BMJ Open|August 2, 2020
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB studyBriony Larance, Marianne Byrne, Nicholas Lintzeris, et al.
The International Journal on Drug Policy|October 9, 2023
Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, AustraliaThomas D Brothers, Dan Lewer, Nicola Jones, et al.
Drug and Alcohol Review|March 18, 2026
Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence SurveyThomas Santo, Chrianna Bharat, Craig Rodgers, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Reinfection with hepatitis C virus following sustained virological response in injection drug usersJason Grebely, Elizabeth Knight, Tyler Ngai, et al.
Journal of Hepatology|April 28, 2023
A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT studyYumi Sheehan, Evan B Cunningham, Amanda Cochrane, et al.
The International Journal on Drug Policy|August 4, 2023
Typology of laws restricting access to methadone treatment in the United States: A latent class analysisAnna Conway, Noa Krawczyk, Frances McGaffey, et al.
Hepatology (Baltimore, Md.)|June 9, 2021
Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in PrisonsAaron G Lim, Jack Stone, Behzad Hajarizadeh, et al.
CMAJ Open|August 1, 2014
Mortality in a large community-based cohort of inner-city residents in Vancouver, CanadaGregory D Deans, Jesse D Raffa, Calvin Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS studyMaryam Alavi, Jason Grebely, Michelle Micallef, et al.
Pageof 37

Showing results (161-170 of 368) with videos related to

Sort By:
Pageof 37
Virus Research|March 28, 2025
Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogeneticsHossain M S Sazzad, Hui Li, Behzad Hajarizadeh, et al.
BMJ Open|August 2, 2020
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB studyBriony Larance, Marianne Byrne, Nicholas Lintzeris, et al.
The International Journal on Drug Policy|October 9, 2023
Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, AustraliaThomas D Brothers, Dan Lewer, Nicola Jones, et al.
Drug and Alcohol Review|March 18, 2026
Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence SurveyThomas Santo, Chrianna Bharat, Craig Rodgers, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Reinfection with hepatitis C virus following sustained virological response in injection drug usersJason Grebely, Elizabeth Knight, Tyler Ngai, et al.
Journal of Hepatology|April 28, 2023
A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT studyYumi Sheehan, Evan B Cunningham, Amanda Cochrane, et al.
The International Journal on Drug Policy|August 4, 2023
Typology of laws restricting access to methadone treatment in the United States: A latent class analysisAnna Conway, Noa Krawczyk, Frances McGaffey, et al.
Hepatology (Baltimore, Md.)|June 9, 2021
Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in PrisonsAaron G Lim, Jack Stone, Behzad Hajarizadeh, et al.
CMAJ Open|August 1, 2014
Mortality in a large community-based cohort of inner-city residents in Vancouver, CanadaGregory D Deans, Jesse D Raffa, Calvin Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS studyMaryam Alavi, Jason Grebely, Michelle Micallef, et al.
Pageof 37